M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers
Clinical trial NCT03554473 · COMPLETED
Trial details
- NCT number
- NCT03554473
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-11
- Primary completion
- 2022-06-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.